Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wurdinger

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Oncotarget|February 6, 2014
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastomaLotte Hiddingh, Bakhos A Tannous, Jian Teng, et al.
Scientific Reports|August 4, 2021
Transcriptomic landscape of blood platelets in healthy donorsAnna Supernat, Marta Popęda, Krzysztof Pastuszak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Mutant sodium channel for tumor therapyBakhos A Tannous, Adam P Christensen, Lisa Pike, et al.
Journal of the National Cancer Institute|December 5, 2013
Role of CYB5A in pancreatic cancer prognosis and autophagy modulationElisa Giovannetti, Qiuyan Wang, Amir Avan, et al.
Frontiers in Cell and Developmental Biology|August 21, 2023
<i>In vitro</i> cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the bloodZahra Eslami-S, Luis Enrique Cortés-Hernández, Ilias Glogovitis, et al.
Neuro-Oncology Advances|July 17, 2023
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategiesMegan Houweling, Anna Giczewska, Kulsoom Abdul, et al.
Neuro-Oncology|October 28, 2020
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtypeJian Teng, Seyedali Hejazi, Lotte Hiddingh, et al.
Brain Pathology (Zurich, Switzerland)|December 17, 2010
Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse modelViola Caretti, Ilse Zondervan, Dimphna H Meijer, et al.
Cancers|May 16, 2023
Platelet-Based Liquid Biopsies through the Lens of Machine LearningSebastian Cygert, Krzysztof Pastuszak, Franciszek Górski, et al.
Neuro-Oncology|November 4, 2017
Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtypeJian Teng, Seyedali Hejazi, Lotte Hiddingh, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Oncotarget|February 6, 2014
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastomaLotte Hiddingh, Bakhos A Tannous, Jian Teng, et al.
Scientific Reports|August 4, 2021
Transcriptomic landscape of blood platelets in healthy donorsAnna Supernat, Marta Popęda, Krzysztof Pastuszak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Mutant sodium channel for tumor therapyBakhos A Tannous, Adam P Christensen, Lisa Pike, et al.
Journal of the National Cancer Institute|December 5, 2013
Role of CYB5A in pancreatic cancer prognosis and autophagy modulationElisa Giovannetti, Qiuyan Wang, Amir Avan, et al.
Frontiers in Cell and Developmental Biology|August 21, 2023
<i>In vitro</i> cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the bloodZahra Eslami-S, Luis Enrique Cortés-Hernández, Ilias Glogovitis, et al.
Neuro-Oncology Advances|July 17, 2023
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategiesMegan Houweling, Anna Giczewska, Kulsoom Abdul, et al.
Neuro-Oncology|October 28, 2020
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtypeJian Teng, Seyedali Hejazi, Lotte Hiddingh, et al.
Brain Pathology (Zurich, Switzerland)|December 17, 2010
Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse modelViola Caretti, Ilse Zondervan, Dimphna H Meijer, et al.
Cancers|May 16, 2023
Platelet-Based Liquid Biopsies through the Lens of Machine LearningSebastian Cygert, Krzysztof Pastuszak, Franciszek Górski, et al.
Neuro-Oncology|November 4, 2017
Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtypeJian Teng, Seyedali Hejazi, Lotte Hiddingh, et al.
Pageof 8